Your browser doesn't support javascript.
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward.
Barrios, Carlos H; Werutsky, Gustavo; Mohar, Alejandro; Ferrigno, Ana S; Müller, Bettina G; Bychkovsky, Brittany L; Castro E, Carlos José; Uribe, Claudia J; Villarreal-Garza, Cynthia; Soto-Perez-de-Celis, Enrique; Gutiérrez-Delgado, Francisco; Kim, Ji Seok; Ismael, Julia; Delgado, Lucia; Santini, Luiz A; Teich, Nelson; Chavez, Pamela C; Liedke, Pedro E R; Exman, Pedro; Barroso-Sousa, Romualdo; Stefani, Stephen D; Cáceres, Suyapa A Bejarano; Rebelatto, Taiane F; Pastrana, Tania; Chavarri-Guerra, Yanin; Vargas, Yolanda; Cazap, Eduardo.
  • Barrios CH; Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: barrios@tummi.org.
  • Werutsky G; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
  • Mohar A; Unidad de Epidemiología, Instituto Nacional de Cancerología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.
  • Ferrigno AS; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo León, Mexico.
  • Müller BG; Department of Medical Oncology, Instituto Nacional del Cáncer, Santiago, Chile.
  • Bychkovsky BL; Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Castro E CJ; Liga Colombiana Contra el Cáncer, Bogota, Colombia.
  • Uribe CJ; Universidad Autónoma de Bucaramanga, Bucaramanga, Colombia.
  • Villarreal-Garza C; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo León, Mexico.
  • Soto-Perez-de-Celis E; Department of Geriatrics, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
  • Gutiérrez-Delgado F; Centro de Estudios y Prevención del Cancer Tuxtla Gutiérrez, Chiapas, México; Latin American School of Oncology (ELO), México City, México.
  • Kim JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Dewpoint Therapeutics, Boston, MA, USA.
  • Ismael J; Gedyt Foundation, Buenos Aires, Argentina.
  • Delgado L; Faculty of Medicine, University of Uruguay, Montevideo, Uruguay; Honorary Commission for the Fight Against Cancer, Montevideo, Uruguay.
  • Santini LA; Center of Strategic Studies of FIOCRUZ (Fundação Oswaldo Cruz), Rio de Janeiro, Brazil.
  • Teich N; Teich Health Care Consulting, Rio de Janeiro, Brazil.
  • Chavez PC; Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.
  • Liedke PER; Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Department of Oncology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Unidade de Pesquisa Clínica em Oncologia, Porto Alegre, Brazil.
  • Exman P; Department of Medical Oncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
  • Barroso-Sousa R; Department of Oncology, Hospital Sírio-Libanês, Brasília, Brazil.
  • Stefani SD; Oncology Department, Oncoclinicas Group, Porto Alegre, Brazil.
  • Cáceres SAB; Medicine Universidad Católica de Honduras, San Pedro Sula, Honduras; Department of Clinical Oncology, Liga Contra el Cáncer, San Pedro Sula, Honduras.
  • Rebelatto TF; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil.
  • Pastrana T; Department of Palliative Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Chavarri-Guerra Y; Department of Hemato-Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
  • Vargas Y; Unidad de Cuidados Paliativos y Clínica de Alivio del Dolor Oncológico, Instituto Oncológico Nacional, Ciudad de Panamá, Panamá.
  • Cazap E; Latin American and Caribbean Society of Medical Oncology (SLACOM), Buenos Aires, Argentina.
Lancet Oncol ; 22(11): e474-e487, 2021 11.
Article in English | MEDLINE | ID: covidwho-1488012
ABSTRACT
The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015 highlighted potential interventions that could advance cancer care in the region by overcoming existing challenges. Areas requiring improvement included insufficient investment in cancer control, non-universal health coverage, fragmented health systems, inequitable concentration of cancer services, inadequate registries, delays in diagnosis or treatment initiation, and insufficient palliative services. Progress has been made in key areas but remains uneven across the region. An unforeseen challenge, the COVID-19 pandemic, strained all resources, and its negative effect on cancer control is expected to continue for years. In this Series paper, we summarise progress in several aspects of cancer control since 2015, and identify persistent barriers requiring commitment of additional resources to reduce the cancer burden in Latin America and the Caribbean.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: SARS-CoV-2 / COVID-19 / Neoplasms Subject: SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Diagnostic study / Screening study Language: English Journal: Lancet Oncol Year: 2021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Document Type: Article Main subject: SARS-CoV-2 / COVID-19 / Neoplasms Subject: SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Diagnostic study / Screening study Language: English Journal: Lancet Oncol Year: 2021
...